Charts, dont forget, with MYX having some 85% of the oral contraceptive market, E4 will cannibalize some of our existing sales. MITHRA'S price action of late is a really good indicator of the future profits of this gamechanger. Im not aware of the profit margins regarding E4,one would think they'd be a lot higher than a generic oral contraceptive. And being a world first definitely has it's advantages,(even with patent protection for 20yrs) With FDA approval and an effective launch campaign i can genuinely see a $1-$1.50 as a realistic price re-rate,also not forgetting a re-inclusion into ASX200 at $1.00 and knocking on the door of minimum market cap for asx100 at $1.50.
if ALL the volume on thursday were short coverings,that still leaves at least 10mill that have to exit as of 4 days ago. I cant wait for the market to re-open and watch them burn.Better still,an announcement of a trading halt,pending price sensitive announcement. Even RICHARDS would have to admit its price sensitive.....hahahaha.
